Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$9 Mln
P/E Ratio
--
P/B Ratio
0.64
Industry P/E
--
Debt to Equity
0.1
ROE
-0.32 %
ROCE
-29.7 %
Div. Yield
0 %
Book Value
12.09
EPS
-4.29
CFO
$-77.51 Mln
EBITDA
$-74.25 Mln
Net Profit
$-142.98 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Precipio (PRPO)
| -1.62 | -19.62 | -18.17 | -12.10 | -37.57 | -14.32 | -54.95 |
|
BSE Sensex*
| 2.39 | 4.18 | 4.86 | 8.78 | 11.89 | 20.62 | 11.13 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Precipio (PRPO)
| -14.66 | -41.06 | -65.13 | -23.67 | 0.98 | -11.26 | -87.02 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 15.28 | 10,289.47 | 14.38 | 12.69 | |
| 70.06 | 9,544.04 | 92.52 | 2.52 | |
| 152.07 | 8,064.21 | -- | -25.23 | |
| 277.22 | 10,728.90 | 773.26 | 1.2 |
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables... simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut. Address: 4 Science Park, New Haven, CT, United States, 06511 Read more
Founder, President, CEO & Director
Mr. Ilan Danieli
Founder, President, CEO & Director
Mr. Ilan Danieli
Headquarters
New Haven, CT
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Precipio Inc (PRPO) stood at $ 17 Mln as on 31-Dec-24
The share price of Precipio Inc (PRPO) is $5.45 (NASDAQ) as of 22-Apr-2025 16:00 EDT. Precipio Inc (PRPO) has given a return of -37.57% in the last 3 years.
Precipio Inc (PRPO) has a market capitalisation of $ 9 Mln as on 22-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Precipio Inc (PRPO) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Precipio Inc (PRPO) and enter the required number of quantities and click on buy to purchase the shares of Precipio Inc (PRPO).
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut. Address: 4 Science Park, New Haven, CT, United States, 06511
The CEO & director of Mr. Ilan Danieli. is Precipio Inc (PRPO), and CFO & Sr. VP is Mr. Ilan Danieli.
There is no promoter pledging in Precipio Inc (PRPO).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,070
|
|
|
1,049
|
|
|
978
|
|
|
820
|
| Precipio Inc. (PRPO) | Ratios |
|---|---|
|
Return on equity(%)
|
-32.35
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
-26.87
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Precipio Inc (PRPO) was $0 Mln.
$0.21
(
